'No difference' in effects of antidepressants and CBT, study suggests

There is 'no difference' in the effects of second generation antidepressants and CBT, a review of available evidence has suggested, but BMA leaders stress GPs should not feel pressured to stop prescribing antidepressants.

CBT is as effective in treating major depression as second generation antidepressants including selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors and others, research published in the BMJ has suggested.

But leading GPs have said GPs should not feel under pressure for prescribing antidepressants to patients for major depression, as more research must be done before the evidence becomes robust enough to prompt changes to recommended guidance.

The US study, a systematic review of 11 randomised controlled trials encompassing 1,500 patients, concluded that there was ‘no difference’ in the benefits and harms of second generation antidepressants over CBT for patients with major depressive disorder.

Given they found that both treatments produce similar benefits, the researchers said GPs should ensure that both options are made available to patients either separately or in combination.

CBT and antidepressants

But they added that the results should be ‘interpreted cautiously’ given the low strength of evidence in some of the studies that fed into the review.

Dr Andrew Green, chairman of the GPC clinical and prescribing subcommittee, said the wide confidence limits made it ‘difficult to draw firm conclusions’ from the study, but if verified it could incite changes to current guidance.

He said: ‘GPs are often criticised for treating depression with medication rather than offering alternatives, but in correctly selected patients drug therapy is safe and effective, and has the advantage of having no delay in treatment and often rapid responses.

‘This can help patients maintain their employment and personal relationships which are so important yet so vulnerable during episodes of depression.

‘In other areas of medicine we are urged to use the intervention with the ‘lowest acquisition cost’, if this principle were applied here then if this study is true guidance might need to change, however the political implications of such a change would be significant given the strong feelings that this issue can raise.’

The researchers said: ‘Given that the benefits of second generation antidepressants and cognitive behavioural therapy do not seem to differ significantly in treating major depressive disorder and that primary care patients may have personal preferences for one first line treatment over the other, both treatments should be made accessible, either alone or in combination, to primary care patients with major depressive disorder.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

NHS app goes live with full rollout to all GP practices promised by July

NHS app goes live with full rollout to all GP practices promised by July

Patients across England can now download an NHS app that will allow them to book...

NICE recommends digital CBT for children with mild depression

NICE recommends digital CBT for children with mild depression

Children and young people with mild depression should have access to digital cognitive...

GPs taking early retirement triple in a decade as tax limits hit workforce

GPs taking early retirement triple in a decade as tax limits hit workforce

Numbers of GPs taking early retirement have tripled over the past decade as tighter...

BMA safety warning as pharmacists gain power to switch prescriptions

BMA safety warning as pharmacists gain power to switch prescriptions

Pharmacists are set to be granted emergency powers to alter patients' prescriptions...

GP funding could rise £60m through deals on QOF, networks and digital health

GP funding could rise £60m through deals on QOF, networks and digital health

GP leaders hope to trigger a 1% boost to practice funding from April - on top of...

GP trainees unfairly denied £20,000 golden hello payments, says BMA

GP trainees unfairly denied £20,000 golden hello payments, says BMA

Some GP trainees expecting £20,000 golden hellos for working in under-doctored areas...